Ceruvia Lifesciences United Kingdom England United States of America Connecticut

Ceruvia Lifesciences Announces First Participant Dosed in BOL-148 Phase 1 Clinical Trial

View original content:https://www.prnewswire.co.uk/news-releases/ceruvia-lifesciences-announces-first-participant-dosed-in-bol-148-phase-1-clinical-trial-301722293.html